SNS: A Centerpiece Conversation with Mark Hurd

 

Global Report on

Technology and the Economy

 

19 Years Providing Weekly Foresight

 

The most accurate predictive report on technology and the global economy,

read by leaders in industry, finance, and government worldwide.

 

 SNS Subscriber Edition Volume 18, Issue 6 Week of February 9, 2015 

 

 

 

***SNS***

 

A Centerpiece Conversation with

 Mark Hurd, CEO, Oracle

 

Hosted by Mark Anderson

 

at the Inaugural

SNS Predictions : West

 

 

 

In This Issue

 

 

Feature:

A Centerpiece Conversation with Mark Hurd

 

About Mark Hurd

 

 

 

Upcoming SNS Events

 

Where's Mark?

 

[Please open the attached .pdf for best viewing.]

 

 

 

Five Global Challenges

 

I: Pandemics

 

Pandemics are the greatest global health issue we face today. What have we learned from the Ebola epidemic, and how should we apply our knowledge?

 

In this first of a series, Mark Anderson discusses one of five Global Challenges - Pandemics - as part of the Park City Institute / SNS / "Future in Review" Speaker Series. Watch now.

 

 

 

 

Publisher's Note: Last week, at our first-ever Predictions : West event, in San Francisco, I had the pleasure of interviewing my friend and guest Oracle CEO Mark Hurd. This is now the third or fourth time I've had the opportunity to interview Mark, and each time I learn something new - not just about Oracle, which one expects, but about larger issues in the worlds of sales, marketing, operations, management, and even human psychology. 

 

This interview was no exception, and members will find that, while we had a great time moving very quickly through cloud computing, Platform as a Service, security, data center management, hardware and software optimization, and other technical issues, plenty of unexpected gems came out in the same half hour, such as understanding Mark's view of the world's demographics in terms of age, income, and sales potential.  I think all of our members will enjoy this conversation as much as I did. - mra.